Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era

Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era

Current treatment guidelines for the management of recurrent glioblastoma (rGBM) are far from definitive, and the prognosis remains dismal. Despite recent advancements in the pharmacological and surgical fields, numerous doubts persist concerning the optimal strategy that clinicians should adopt for...

Full description

Bibliographic Details
Main Authors: Augusto Leone, Antonio Colamaria, Nicola Pio Fochi, Matteo Sacco, Matteo Landriscina, Giovanni Parbonetti, Matteo de Notaris, Giulia Coppola, Elena De Santis, Guido Giordano, Francesco Carbone
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomedicines
Subjects:
recurrent glioblastoma
brain tumor
review
glioblastoma treatment
chemotherapy
regorafenib
Online Access:https://www.mdpi.com/2227-9059/10/8/1927

Internet

https://www.mdpi.com/2227-9059/10/8/1927

Similar Items